Literature DB >> 28385916

Mild aerobic exercise blocks elastin fiber fragmentation and aortic dilatation in a mouse model of Marfan syndrome associated aortic aneurysm.

Christine Gibson1, Cory Nielsen1, Ramona Alex1, Kimbal Cooper1, Michael Farney1, Douglas Gaufin1, Jason Z Cui2, Cornelis van Breemen2, Tom L Broderick3, Johana Vallejo-Elias3, Mitra Esfandiarei4,2.   

Abstract

Regular low-impact physical activity is generally allowed in patients with Marfan syndrome, a connective tissue disorder caused by heterozygous mutations in the fibrillin-1 gene. However, being above average in height encourages young adults with this syndrome to engage in high-intensity contact sports, which unfortunately increases the risk for aortic aneurysm and rupture, the leading cause of death in Marfan syndrome. In this study, we investigated the effects of voluntary (cage-wheel) or forced (treadmill) aerobic exercise at different intensities on aortic function and structure in a mouse model of Marfan syndrome. Four-week-old Marfan and wild-type mice were subjected to voluntary and forced exercise regimens or sedentary lifestyle for 5 mo. Thoracic aortic tissue was isolated and subjected to structural and functional studies. Our data showed that exercise improved aortic wall structure and function in Marfan mice and that the beneficial effect was biphasic, with an optimum at low intensity exercise (55-65% V̇o2max) and tapering off at a higher intensity of exercise (85% V̇o2max). The mechanism underlying the reduced elastin fragmentation in Marfan mice involved reduction of the expression of matrix metalloproteinases 2 and 9 within the aortic wall. These findings present the first evidence of potential beneficial effects of mild exercise on the structural integrity of the aortic wall in Marfan syndrome associated aneurysm. Our finding that moderate, but not strenuous, exercise protects aortic structure and function in a mouse model of Marfan syndrome could have important implications for the medical care of young Marfan patients.NEW & NOTEWORTHY The present study provides conclusive scientific evidence that daily exercise can improve aortic health in a mouse model of Marfan syndrome associated aortic aneurysm, and it establishes the threshold for the exercise intensity beyond which exercise may not be as protective. These findings establish a platform for a new focus on promoting regular exercise in Marfan patients at an optimum intensity and create a paradigm shift in clinical care of Marfan patients suffering from aortic aneurysm complications.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  Marfan syndrome; aortic aneurysm; aortic elasticity; elastin fragmentation; mild exercise

Mesh:

Substances:

Year:  2017        PMID: 28385916     DOI: 10.1152/japplphysiol.00132.2017

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  14 in total

1.  Sildenafil Prevents Marfan-Associated Emphysema and Early Pulmonary Artery Dilation in Mice.

Authors:  Zoe White; Nadia Milad; Arash Y Tehrani; Jennifer Lamothe; James C Hogg; Mitra Esfandiarei; Michael Seidman; Steven Booth; Tillie-Louise Hackett; Mathieu C Morissette; Pascal Bernatchez
Journal:  Am J Pathol       Date:  2019-05-22       Impact factor: 4.307

Review 2.  Marfan syndrome; A connective tissue disease at the crossroads of mechanotransduction, TGFβ signaling and cell stemness.

Authors:  Francesco Ramirez; Cristina Caescu; Elisabeth Wondimu; Josephine Galatioto
Journal:  Matrix Biol       Date:  2017-08-04       Impact factor: 11.583

Review 3.  Thoracic Aortic Dilation: Implications for Physical Activity and Sport Participation.

Authors:  Emanuele Monda; Federica Verrillo; Marta Rubino; Giuseppe Palmiero; Adelaide Fusco; Annapaola Cirillo; Martina Caiazza; Natale Guarnaccia; Alfredo Mauriello; Michele Lioncino; Alessia Perna; Gaetano Diana; Antonello D'Andrea; Eduardo Bossone; Paolo Calabrò; Giuseppe Limongelli
Journal:  Diagnostics (Basel)       Date:  2022-06-04

4.  Marfan on the Move.

Authors:  Vivian de Waard
Journal:  J Am Heart Assoc       Date:  2017-09-25       Impact factor: 5.501

5.  Differences in the Thoracic Aorta by Region and Sex in a Murine Model of Marfan Syndrome.

Authors:  Francesc Jiménez-Altayó; Anna-Maria Siegert; Fabio Bonorino; Thayna Meirelles; Laura Barberà; Ana P Dantas; Elisabet Vila; Gustavo Egea
Journal:  Front Physiol       Date:  2017-11-15       Impact factor: 4.566

Review 6.  The Potential Beneficial Effects of Resveratrol on Cardiovascular Complications in Marfan Syndrome Patients⁻Insights from Rodent-Based Animal Studies.

Authors:  Mitzi M van Andel; Maarten Groenink; Aeilko H Zwinderman; Barbara J M Mulder; Vivian de Waard
Journal:  Int J Mol Sci       Date:  2019-03-05       Impact factor: 5.923

7.  In vivo characterization of doxycycline-mediated protection of aortic function and structure in a mouse model of Marfan syndrome-associated aortic aneurysm.

Authors:  Jason Z Cui; Ling Lee; Xiaoye Sheng; Fanny Chu; Christine P Gibson; Taline Aydinian; David C Walker; George G S Sandor; Pascal Bernatchez; Glen F Tibbits; Cornelis van Breemen; Mitra Esfandiarei
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

8.  The influence of fibrillin-1 and physical activity upon tendon tissue morphology and mechanical properties in mice.

Authors:  Peter H T Tran; Tanja Skrba; Elisabeth Wondimu; Giuseppina Galatioto; René Brüggebusch Svensson; Annesofie T Olesen; Abigail L Mackey; S Peter Magnusson; Francesco Ramirez; Michael Kjaer
Journal:  Physiol Rep       Date:  2019-11

9.  Physical activity and the risk of abdominal aortic aneurysm: a systematic review and meta-analysis of prospective studies.

Authors:  Dagfinn Aune; Abhijit Sen; Elsa Kobeissi; Mark Hamer; Teresa Norat; Elio Riboli
Journal:  Sci Rep       Date:  2020-12-18       Impact factor: 4.379

10.  Cardiac Rehabilitation Protects Against the Expansion of Abdominal Aortic Aneurysm.

Authors:  Atsuko Nakayama; Hiroyuki Morita; Masatoshi Nagayama; Katsuyuki Hoshina; Yukari Uemura; Hitonobu Tomoike; Issei Komuro
Journal:  J Am Heart Assoc       Date:  2018-02-27       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.